無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

修復されたDNAシーケンシングプラットフォーム市場:世界の機会分析と業界予測

Refurbished DNA Sequencing Platforms Market - Global Opportunity Analysis and Industry Forecast, 2017-2023

発行 Allied Market Research 商品コード 622020
出版日 ページ情報 英文 95 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.03円で換算しております。
Back to Top
修復されたDNAシーケンシングプラットフォーム市場:世界の機会分析と業界予測 Refurbished DNA Sequencing Platforms Market - Global Opportunity Analysis and Industry Forecast, 2017-2023
出版日: 2018年03月01日 ページ情報: 英文 95 Pages
概要

当レポートでは、世界の修復されたDNAシーケンシングプラットフォーム市場について調査し、市場の概要と今後の予測、セグメント別市場、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
  • 特許分析
  • ポーターズファイブフォース分析
  • 市場シェア分析
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会

第4章 地域別市場

  • 概要
  • 米国
  • その他

第8章 企業プロファイル

  • ILLUMINA, INC
  • THERMO FISHER SCIENTIFIC, INC
  • 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG)
  • BECKMAN COULTER
  • LI-COR
図表

List of Tables

  • TABLE 1. GLOBAL REFURBISHED DNA SEQUENCING PLATFORMS MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 2. ILLUMINA, INC: COMPANY SNAPSHOT
  • TABLE 3. THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
  • TABLE 4. ROCHE.: COMPANY SNAPSHOT
  • TABLE 5. BECKMAN COULTER: COMPANY SNAPSHOT
  • TABLE 6. LI-COR: COMPANY SNAPSHOT

List of Figures

  • FIGURE 1. TOP INVESTMENT POCKETS: GLOBAL DNA SEQUENCING MARKET, BY APPLICATION
  • FIGURE 2. TOP WINNING STRATEGIES: NATURE AND TYPE
  • FIGURE 3. TOP WINNING STRATEGIES: NATURE AND COMPANY
  • FIGURE 4. BARGAINING POWER OF BUYERS
  • FIGURE 5. BARGAINING POWER OF SUPPLIERS
  • FIGURE 6. THREAT OF NEW ENTRANTS
  • FIGURE 7. THREAT OF SUBSTITUTION
  • FIGURE 8. COMPETITIVE RIVALRY
  • FIGURE 9. MARKET SHARE ANALYSIS
  • FIGURE 10. U.S. REFURBISHED DNA SEQUENCING PLATFORMS MARKET, 2016-2023 ($MILLION)
  • FIGURE 11. REST OF THE WORLD REFURBISHED DNA SEQUENCING PLATFORMS MARKET, 2016-2023 ($MILLION)
  • FIGURE 12. ILLUMINA, INC: NET SALES, 2014-2017 ($MILLION)
  • FIGURE 13. ILLUMINA, INC: REVENUE BY SEGMENT, 2015 (%)
  • FIGURE 14. THERMO FISHER SCIENTIFIC, INC: NET SALES, 2014-2017 ($MILLION)
  • FIGURE 15. THERMO FISHER SCIENTIFIC, INC: REVENUE BY SEGMENT, 2015 (%)
  • FIGURE 16. THERMO FISHER SCIENTIFIC, INC: REVENUE BY GEOGRAPHY, 2015 (%)
  • FIGURE 17. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG): NET SALES, 2014-2017 ($MILLION)
  • FIGURE 18. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG): REVENUE BY SEGMENT, 2015 (%)
  • FIGURE 19. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG): REVENUE BY GEOGRAPHY, 2015 (%)
  • FIGURE 20. BECKMAN COULTER: NET SALES, 2014-2017 ($MILLION)
  • FIGURE 21. BECKMAN COULTER: REVENUE BY SEGMENT, 2015 (%)
  • FIGURE 22. BECKMAN COULTER: REVENUE BY GEOGRAPHY, 2015 (%)
  • FIGURE 23. LI-COR: NET SALES, 2014-2017 ($MILLION)
  • FIGURE 24. LI-COR: REVENUE BY SEGMENT, 2015 (%)
  • FIGURE 25. LI-COR: REVENUE BY GEOGRAPHY, 2015 (%)
目次
Product Code: LI 184594

The global refurbished DNA sequencing platforms market was valued at $41 million in 2016 and is expected to reach $112 million in 2023, registering a CAGR of 15.0% from 2017 to 2023. DNA sequencing is a technology in which several DNA strands could be sequenced through massive parallelization. Low cost, high accuracy and speed, and precise results even from low sample input are the main advantages DNA sequencing offers over microarray and other genomic analysis methods. Refurbished and used DNA sequencing platforms are relatively inexpensive instruments used for DNA sequencing, when compared with new DNA sequencing platforms.

In addition, the growth in number of genome mapping programs globally and increase in R&D investment drive the market growth. However, lack of skilled professionals, ethical & legal limitation related to DNA sequencing, and standardization concerns in sequencing procedures impede the market growth. Conversely, use of cloud computing as a potential data management service and the untapped emerging countries offer lucrative opportunities for the market players.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the refurbished global DNA sequencing market, with current trends and future estimations to elucidate the imminent investment pockets.
  • A quantitative analysis from 2017 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities is discussed.
  • Key market players are profiled and their strategies are analyzed thoroughly, which help understand the competitive outlook of the market.
  • Porter's Five Forces model interprets the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition in the key players.

KEY MARKET SEGMENTS

By Region

  • U.S.
  • Rest of the world

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top investment pockets
    • 3.2.2. Top winning strategies
  • 3.3. PATENTS ANALYSIS
    • 3.3.1. Patent analysis by year
    • 3.3.2. Patent analysis by region
  • 3.4. PORTERS FIVE FORCES ANALYSIS
  • 3.5. MARKET SHARE ANALYSIS (2016)
  • 3.6. MARKET DYNAMICS
    • 3.6.1. Drivers
    • 3.6.2. Restraints
    • 3.6.3. Opportunities

CHAPTER 4 GLOBAL REFURBISHED DNA SEQUENCING PLARFORMS MARKET, BY REGION

  • 4.1. OVERVIEW
    • 4.1.1. Market size & forecast
  • 4.2. U.S.
    • 4.2.1. Key market trends
    • 4.2.2. Key growth factors and opportunities
    • 4.2.3. Market size & forecast
  • 4.3. REST OF THE WORLD
    • 4.3.1. Key market trends
    • 4.3.2. Key growth factors and opportunities
    • 4.3.3. Market size & forecast

CHAPTER 5 COMPANY PROFILES

  • 5.1. ILLUMINA, INC
    • 5.1.1. Operating business segments
    • 5.1.2. Business performance
  • 5.2. THERMO FISHER SCIENTIFIC, INC
    • 5.2.1. Operating business segments
    • 5.2.2. Business performance
    • 5.2.3. Key strategic moves and developments
  • 5.3. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG)
    • 5.3.1. Operating business segments
    • 5.3.2. Business performance
    • 5.3.3. Key strategic moves and developments
  • 5.4. BECKMAN COULTER
    • 5.4.1. Operating business segments
    • 5.4.2. Business performance
    • 5.4.3. Key strategic moves and developments
  • 5.5. LI-COR
    • 5.5.1. Operating business segments
    • 5.5.2. Business performance
    • 5.5.3. Key strategic moves and developments
Back to Top